Logo image of PVL.PA

PLASTIVALOIRE (PVL.PA) Stock Fundamental Analysis

EPA:PVL - Euronext Paris - Matif - FR0013252186 - Common Stock - Currency: EUR

1.28  -0.03 (-2.29%)

Fundamental Rating

2

Taking everything into account, PVL scores 2 out of 10 in our fundamental rating. PVL was compared to 67 industry peers in the Chemicals industry. Both the profitability and financial health of PVL have multiple concerns. PVL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

PVL had negative earnings in the past year.
In the past year PVL had a positive cash flow from operations.
In the past 5 years PVL reported 4 times negative net income.
Each year in the past 5 years PVL had a positive operating cash flow.
PVL.PA Yearly Net Income VS EBIT VS OCF VS FCFPVL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

PVL's Return On Assets of -6.28% is on the low side compared to the rest of the industry. PVL is outperformed by 73.13% of its industry peers.
PVL has a worse Return On Equity (-23.23%) than 77.61% of its industry peers.
PVL's Return On Invested Capital of 1.40% is in line compared to the rest of the industry. PVL outperforms 43.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PVL is below the industry average of 6.34%.
Industry RankSector Rank
ROA -6.28%
ROE -23.23%
ROIC 1.4%
ROA(3y)-3.76%
ROA(5y)-2.43%
ROE(3y)-13.19%
ROE(5y)-8.49%
ROIC(3y)2.18%
ROIC(5y)N/A
PVL.PA Yearly ROA, ROE, ROICPVL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

PVL's Operating Margin of 1.26% is in line compared to the rest of the industry. PVL outperforms 41.79% of its industry peers.
PVL's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 48.03%, PVL is in the better half of the industry, outperforming 70.15% of the companies in the same industry.
PVL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.26%
PM (TTM) N/A
GM 48.03%
OM growth 3Y-24.59%
OM growth 5Y-25.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y2.85%
PVL.PA Yearly Profit, Operating, Gross MarginsPVL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PVL is destroying value.
Compared to 1 year ago, PVL has about the same amount of shares outstanding.
The number of shares outstanding for PVL remains at a similar level compared to 5 years ago.
The debt/assets ratio for PVL is higher compared to a year ago.
PVL.PA Yearly Shares OutstandingPVL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
PVL.PA Yearly Total Debt VS Total AssetsPVL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PVL has an Altman-Z score of 1.62. This is a bad value and indicates that PVL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.62, PVL is doing worse than 71.64% of the companies in the same industry.
A Debt/Equity ratio of 1.21 is on the high side and indicates that PVL has dependencies on debt financing.
PVL's Debt to Equity ratio of 1.21 is on the low side compared to the rest of the industry. PVL is outperformed by 80.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 1.62
ROIC/WACC0.37
WACC3.76%
PVL.PA Yearly LT Debt VS Equity VS FCFPVL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.39 indicates that PVL should not have too much problems paying its short term obligations.
PVL has a Current ratio of 1.39. This is in the lower half of the industry: PVL underperforms 68.66% of its industry peers.
PVL has a Quick Ratio of 1.21. This is a normal value and indicates that PVL is financially healthy and should not expect problems in meeting its short term obligations.
PVL has a Quick ratio (1.21) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.21
PVL.PA Yearly Current Assets VS Current LiabilitesPVL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

1

3. Growth

3.1 Past

PVL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -175.68%.
The Revenue has decreased by -7.04% in the past year.
PVL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.69% yearly.
EPS 1Y (TTM)-175.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19400%
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y1.28%
Revenue growth 5Y-0.69%
Sales Q2Q%-11.27%

3.2 Future

The Earnings Per Share is expected to grow by 54.67% on average over the next years. This is a very strong growth
Based on estimates for the next years, PVL will show a decrease in Revenue. The Revenue will decrease by -1.59% on average per year.
EPS Next Y-1400%
EPS Next 2Y76.07%
EPS Next 3Y54.67%
EPS Next 5YN/A
Revenue Next Year-10.02%
Revenue Next 2Y-4.83%
Revenue Next 3Y-1.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PVL.PA Yearly Revenue VS EstimatesPVL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PVL.PA Yearly EPS VS EstimatesPVL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PVL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PVL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PVL.PA Price Earnings VS Forward Price EarningsPVL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PVL is valued cheaper than 95.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.78
PVL.PA Per share dataPVL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as PVL's earnings are expected to grow with 54.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.07%
EPS Next 3Y54.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PVL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLASTIVALOIRE

EPA:PVL (6/27/2025, 7:00:00 PM)

1.28

-0.03 (-2.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-28 2025-08-28
Inst Owners1.03%
Inst Owner ChangeN/A
Ins Owners54.69%
Ins Owner ChangeN/A
Market Cap28.33M
Analysts45.71
Price Target1.58 (23.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF 0.78
P/B 0.15
P/tB 0.23
EV/EBITDA 4.78
EPS(TTM)-2.04
EYN/A
EPS(NY)-1.51
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.63
OCFY127.49%
SpS31.79
BVpS8.77
TBVpS5.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.28%
ROE -23.23%
ROCE 2.07%
ROIC 1.4%
ROICexc 1.4%
ROICexgc 1.66%
OM 1.26%
PM (TTM) N/A
GM 48.03%
FCFM N/A
ROA(3y)-3.76%
ROA(5y)-2.43%
ROE(3y)-13.19%
ROE(5y)-8.49%
ROIC(3y)2.18%
ROIC(5y)N/A
ROICexc(3y)2.53%
ROICexc(5y)N/A
ROICexgc(3y)3.11%
ROICexgc(5y)N/A
ROCE(3y)3.17%
ROCE(5y)N/A
ROICexcg growth 3Y-20.84%
ROICexcg growth 5Y-21.45%
ROICexc growth 3Y-19.92%
ROICexc growth 5Y-21.2%
OM growth 3Y-24.59%
OM growth 5Y-25.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y2.85%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA 4.41
Cap/Depr 85.85%
Cap/Sales 5.42%
Interest Coverage 0.89
Cash Conversion 67.81%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.21
Altman-Z 1.62
F-Score5
WACC3.76%
ROIC/WACC0.37
Cap/Depr(3y)60.25%
Cap/Depr(5y)56.65%
Cap/Sales(3y)3.98%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-175.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19400%
EPS Next Y-1400%
EPS Next 2Y76.07%
EPS Next 3Y54.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y1.28%
Revenue growth 5Y-0.69%
Sales Q2Q%-11.27%
Revenue Next Year-10.02%
Revenue Next 2Y-4.83%
Revenue Next 3Y-1.59%
Revenue Next 5YN/A
EBIT growth 1Y-70.23%
EBIT growth 3Y-23.63%
EBIT growth 5Y-25.84%
EBIT Next Year674.65%
EBIT Next 3Y102.78%
EBIT Next 5YN/A
FCF growth 1Y-107.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.76%
OCF growth 3Y-26.28%
OCF growth 5Y-7.25%